Talaris Therapeutics Inc.

NASDAQ: TALS · Real-Time Price · USD
2.72
-0.02 (-0.73%)
At close: Oct 19, 2023, 10:00 PM

Talaris Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.94 -0.06 -0.92
PEG Ratio
n/a -0.08 0.02
PS Ratio
n/a n/a n/a
PB Ratio
0.23 0.02 0.18
P/FCF Ratio
-0.89 -0.07 -1.05
P/OCF Ratio
-0.89 -0.07 -1.11
OCF/S Ratio
n/a n/a n/a
Debt / Equity Ratio
0.00 0.02 n/a
Quick Ratio
30.18 16.19 30.86
Current Ratio
30.18 16.19 30.86
Asset Turnover
n/a n/a n/a
Interest Coverage
n/a -29.61 n/a
Return on Equity
-0.24 -0.38 -0.2
Return on Assets
-0.24 -0.35 -0.19
Return on Invested Capital
-0.3 -0.39 -0.2
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a n/a
Net Profit Margin
n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a
Operating Profit Margin
n/a n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a n/a